Location: Redwood City, CA
CIK: 0001582844 · Show all filings
Period: Q4 2020 (← Previous) (Next →)
Filing Date: Feb 16, 2021
Total Value: $367M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| CLDX | CELLDEX THERAPEUTICS INC NEW | 1,627,500 | $28.51M | 7.8% | $7.56 | +138.1% | COM NEW | 15117B202 |
| — | SAGE THERAPEUTICS INC | 255,800 | $22.13M | 6.0% | $64.18 | — | COM | 78667J108 |
| KURA | KURA ONCOLOGY INC | 637,500 | $20.82M | 5.7% | $15.54 | +126.2% | COM | 50127T109 |
| LRMR | LARIMAR THERAPEUTICS INC | 863,100 | $18.48M | 5.0% | $11.97 | +67.4% | COM | 517125100 |
| — | MERSANA THERAPEUTICS INC | 694,000 | $18.47M | 5.0% | $7.27 | — | COM | 59045L106 |
| CMPS | COMPASS PATHWAYS PLC | 319,000 | $15.2M | 4.1% | $34.90 | — | SPONSORED ADS | 20451W101 |
| — | VISTAGEN THERAPEUTICS INC | 7,500,000 | $14.55M | 4.0% | $1.94 | — | COM NEW | 92840H202 |
| — | ATHIRA PHARMA INC | 393,000 | $13.46M | 3.7% | $19.69 | — | COM | 04746L104 |
| IMVT | IMMUNOVANT INC | 283,500 | $13.1M | 3.6% | $24.36 | +89.8% | COM | 45258J102 |
| — | TRILLIUM THERAPEUTICS INC | 803,000 | $11.81M | 3.2% | $14.21 | — | COM NEW | 89620X506 |
| ARWR | ARROWHEAD PHARMACEUTICALS IN | 139,000 | $10.66M | 2.9% | $40.37 | +58.4% | COM | 04280A100 |
| — | 89BIO INC | 434,400 | $10.59M | 2.9% | $25.61 | — | COM | 282559103 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 465,500 | $10.35M | 2.8% | $17.89 | +15.9% | COM | 87164F105 |
| APLS | APELLIS PHARMACEUTICALS INC | 167,054 | $9.555M | 2.6% | $28.50 | +48.4% | COM | 03753U106 |
| — | BCLS ACQUISITION CORP | 842,500 | $9.385M | 2.6% | $11.14 | — | COM CL A | G0904B105 |
| — | SURFACE ONCOLOGY INC | 999,500 | $9.235M | 2.5% | $6.83 | — | COM | 86877M209 |
| — | CATALYST BIOSCIENCES INC | 1,357,500 | $8.566M | 2.3% | $4.48 | — | COM NEW | 14888D208 |
| — | IVERIC BIO INC | 1,212,500 | $8.378M | 2.3% | $6.16 | — | COM | 46583P102 |
| FULC | FULCRUM THERAPEUTICS INC | 682,500 | $7.992M | 2.2% | $11.72 | -3.5% | COM | 359616109 |
| REPL | REPLIMUNE GROUP INC | 207,500 | $7.916M | 2.2% | $41.67 | 0.0% | COM | 76029N106 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 164,800 | $7.647M | 2.1% | $15.98 | +148.5% | COM | 462260100 |
| — | CONCERT PHARMACEUTICALS INC | 537,500 | $6.794M | 1.8% | $11.07 | — | COM | 206022105 |
| ALT | ALTIMMUNE INC | 578,500 | $6.525M | 1.8% | $8.67 | +36.0% | COM NEW | 02155H200 |
| RNAM | AVIDITY BIOSCIENCES INC | 246,200 | $6.283M | 1.7% | $28.88 | +1.0% | COM | 05370A108 |
| — | JIYA ACQUISITION CORP | 562,500 | $5.794M | 1.6% | $10.30 | — | COM CL A | 47760M102 |
| STOK | STOKE THERAPEUTICS INC | 92,500 | $5.729M | 1.6% | $45.84 | 0.0% | COM | 86150R107 |
| — | VERASTEM INC | 2,400,000 | $5.112M | 1.4% | $2.55 | — | COM | 92337C104 |
| — | HEALTH SCIENCES ACQ CORP 2 | 392,500 | $5.028M | 1.4% | $11.00 | — | ORD SHS | G4411D109 |
| — | AVADEL PHARMACEUTICALS PLC | 705,218 | $4.711M | 1.3% | $7.66 | — | SPONSORED ADR | 05337M104 |
| — | CURIS INC | 530,000 | $4.341M | 1.2% | $8.19 | — | COM NEW | 231269200 |
| — | BIOHAVEN PHARMACTL HLDG CO L | 50,000 | $4.286M | 1.2% | — | — | Call | G11196105 |
| — | PRAXIS PRECISION MEDICINES I | 75,645 | $4.162M | 1.1% | $55.02 | — | COM | 74006W108 |
| — | RAPT THERAPEUTICS INC | 209,600 | $4.14M | 1.1% | $32.20 | — | COM | 75382E109 |
| RLMD | RELMADA THERAPEUTICS INC | 120,000 | $3.848M | 1.0% | $41.08 | -16.3% | COM | 75955J402 |
| CCCC | C4 THERAPEUTICS INC | 110,000 | $3.644M | 1.0% | $29.00 | 0.0% | COM STK | 12529R107 |
| MDGL | MADRIGAL PHARMACEUTICALS INC | 32,500 | $3.613M | 1.0% | $122.23 | 0.0% | COM | 558868105 |
| — | CLEARSIDE BIOMEDICAL INC | 1,250,000 | $3.425M | 0.9% | $2.15 | — | COM | 185063104 |
| — | CYMABAY THERAPEUTICS INC | 330,000 | $1.894M | 0.5% | $7.24 | — | COM | 23257D103 |
| — | ONCORUS INC | 53,500 | $1.73M | 0.5% | $32.34 | — | COM | 68236R103 |
| ALDX | ALDEYRA THERAPEUTICS INC | 192,500 | $1.321M | 0.4% | $4.94 | +42.1% | COM | 01438T106 |
| XENE | XENON PHARMACEUTICALS INC | 80,000 | $1.23M | 0.3% | $8.16 | +43.5% | COM | 98420N105 |
| — | CYCLACEL PHARMACEUTICALS INC | 150,000 | $1.172M | 0.3% | $7.81 | — | COM | 23254L603 |
| RCKT | ROCKET PHARMACEUTICALS INC | 20,000 | $1.097M | 0.3% | $36.45 | 0.0% | COM | 77313F106 |
| PMVP | PMV PHARMACEUTICALS INC | 15,000 | $923K | 0.3% | $39.23 | 0.0% | COM | 69353Y103 |
| WVE | WAVE LIFE SCIENCES LTD | 107,500 | $846K | 0.2% | $9.41 | -10.8% | SHS | Y95308105 |
| FDMT | 4D MOLECULAR THERAPEUTICS IN | 20,000 | $829K | 0.2% | $41.28 | 0.0% | COM | 35104E100 |
| ANNX | ANNEXON INC | 25,000 | $626K | 0.2% | $23.46 | +9.7% | COM | 03589W102 |
| — | KARUNA THERAPEUTICS INC | 5,000 | $508K | 0.1% | $85.53 | — | COM | 48576A100 |
| AXSM | AXSOME THERAPEUTICS INC | 6,000 | $489K | 0.1% | $23.68 | +215.8% | COM | 05464T104 |
| — | PANACEA ACQUISITION CORP | 93,332 | $299K | 0.1% | $3.20 | — | *W EXP 07/07/202 | 698102118 |
| NVAX | NOVAVAX INC | 2,500 | $279K | 0.1% | $106.29 | 0.0% | COM NEW | 670002401 |